Immunotech Biopharm Ltd Ordinary Shares 06978

Morningstar Rating
HK$2.78 +0.09 (3.35%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

06978 is trading at a 627% premium.
Price
HK$2.66
Fair Value
HK$8.35
Uncertainty
Extreme
1-Star Price
HK$986.30
5-Star Price
HK$6.94
Economic Moat
Xch
Capital Allocation

Trading Information

Previous Close Price
HK$2.69
Day Range
HK$2.692.84
52-Week Range
HK$2.215.00
Bid/Ask
HK$2.72 / HK$2.78
Market Cap
HK$1.43 Bil
Volume/Avg
128,000 / 142,898

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield

Company Profile

Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
202

Comparables

Valuation

Metric
06978
09966
09969
Price/Earnings (Normalized)
Price/Book Value
2.761.70
Price/Sales
16.4813.68
Price/Cash Flow
Price/Earnings
06978
09966
09969

Financial Strength

Metric
06978
09966
09969
Quick Ratio
0.364.423.74
Current Ratio
0.384.613.82
Interest Coverage
−37.83−25.20−25.88
Quick Ratio
06978
09966
09969

Profitability

Metric
06978
09966
09969
Return on Assets (Normalized)
−24.06%−8.50%−4.69%
Return on Equity (Normalized)
−267.27%−11.48%−6.63%
Return on Invested Capital (Normalized)
−30.83%−12.12%−7.87%
Return on Assets
06978
09966
09969

Biotechnology Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Novo Nordisk AS ADR
NVO
LmbpmzsbzRnhf$516.0 Bil
Vertex Pharmaceuticals Inc
VRTX
ZrxyvvkhCqwzmd$117.1 Bil
Regeneron Pharmaceuticals Inc
REGN
PtqfpcpVybfq$111.8 Bil
Alnylam Pharmaceuticals Inc
ALNY
WjwywwflbLcdkdp$34.6 Bil
argenx SE ADR
ARGX
MtlwdqhChl$33.0 Bil
BioNTech SE ADR
BNTX
JphczqjwWypx$28.5 Bil
Moderna Inc
MRNA
SxzzckltpVtnz$23.5 Bil
United Therapeutics Corp
UTHR
RywlbxjQkvc$15.6 Bil
Biomarin Pharmaceutical Inc
BMRN
FfftlgzlMdyvvk$13.0 Bil
Incyte Corp
INCY
CdhqsbxpNrjbrr$12.9 Bil

Sponsor Center